OTC Pharmaceuticals - Central Africa

Revenue in the OTC Pharmaceuticals market amounts to US$450.90m in 2024. The market is expected to grow annually by 6.04% (CAGR 2024-2029).
The market's largest segment is the segment Vitamins & Minerals with a market volume of US$107.30m in 2024.
In global comparison, most revenue is generated United States (US$41bn in 2024).
In relation to total population figures, per person revenues of US$4.67 are generated in 2024.
In the OTC Pharmaceuticals market, 0.8% of total revenue will be generated through online sales by 2024.

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Analgesics (e.g. Asprin, Paracetamol)
Cough & Cold remedies (e.g. Vicks VapoRub)
Vitamins and Minerals
Skin treatment products

Prescription medicines
Homeopathic remedies

The OTC Pharmaceuticals market in Central Africa is witnessing significant growth and development due to various factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors are all contributing to the expansion of the OTC Pharmaceuticals market in this region.

Customer preferences in Central Africa are playing a crucial role in the growth of the OTC Pharmaceuticals market. Consumers in this region are increasingly seeking accessible and affordable healthcare solutions. They prefer self-medication and are more inclined towards purchasing over-the-counter pharmaceutical products for common ailments and minor health issues.

This shift in customer preferences is driving the demand for OTC Pharmaceuticals in Central Africa. Trends in the market are also influencing the growth of the OTC Pharmaceuticals market in Central Africa. One of the key trends is the increasing availability and accessibility of OTC pharmaceutical products.

Pharmacies and drugstores are expanding their product offerings to cater to the growing demand for over-the-counter medications. Additionally, the rise of e-commerce platforms has made it easier for consumers to purchase OTC pharmaceutical products online, further boosting the market growth. Local special circumstances in Central Africa are contributing to the development of the OTC Pharmaceuticals market.

Limited access to healthcare facilities in remote areas and the high cost of prescription medications are some of the factors driving the demand for over-the-counter alternatives. Additionally, the prevalence of common ailments such as cold, cough, and fever in this region also fuels the demand for OTC pharmaceutical products. Underlying macroeconomic factors are also playing a significant role in the growth of the OTC Pharmaceuticals market in Central Africa.

The steady economic growth in the region has led to an increase in disposable income, allowing consumers to spend more on healthcare products. Furthermore, the growing population in Central Africa is creating a larger consumer base for OTC pharmaceutical products, driving the market expansion. In conclusion, the OTC Pharmaceuticals market in Central Africa is experiencing significant growth and development due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors.

The shift in customer preferences towards accessible and affordable healthcare solutions, the increasing availability of OTC pharmaceutical products, limited access to healthcare facilities, and the steady economic growth in the region are all contributing to the expansion of the market.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Consumer market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.